How many do we need?

How many do we need?

This morning we learned of yet another closed loop insulin delivery system, i.e. artificial pancreas under development. Per a post on the Drug Delivery web site;

“Cellnovo (EPA:CLNV) and Diabeloop said this week they are launching a CE Mark cross-over registration study for an artificial pancreas device Diabeloop is developing which uses Cellnovo’s insulin pump . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.